Administration/Program Operations, and Biostatistics Data Mgt. & Array Analyses
管理/程序操作和生物统计数据管理。
基本信息
- 批准号:7617340
- 负责人:
- 金额:$ 9.02万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-12-01 至 2013-11-30
- 项目状态:已结题
- 来源:
- 关键词:AccountingAcute leukemiaAddressAdvisory CommitteesAffectBiometryBiostatistics CoreBudgetsChromosome abnormalityClinicalCollaborationsCommunicationConflict (Psychology)Coordination and CollaborationCredentialingDataData AnalysesData SetDatabasesDevelopmentDrug FormulationsEffectivenessEtiologyEvaluationEvaluation ResearchExpenditureExperimental DesignsGleanGrantHousingHuman ResourcesInformation ServicesInstitutionInvestigationLaboratoriesManuscriptsModelingOhioOnline SystemsOperative Surgical ProceduresOutcomeParticipantPreparationProceduresProgram EffectivenessProgram Research Project GrantsPublicationsReportingResearchResearch DesignResearch PersonnelResolutionResourcesReview CommitteeRoleSecureServicesStandardizationStatistical Data InterpretationTimeUniversitiesabstractingbasecomputerized data processingdata integrationdata managementdata sharingdesignmeetingsmemberprogramsquality assurancestatisticsweb site
项目摘要
The Administrative and Biostatistics Core will provide critical centralized grant administration, data
jrocessing, new microarray data analysis, and all statistical support for the projects. This Core will also
serve to amalgamate the investigators, their experimental findings and their ideas, evaluation of research
fforts and critically direct the summary efforts toward maintaining a highly integrated program outcome. The
Specific Aims of the Administrative and Biostatistics Core are: 1) Provide administrative services to the
nvestigators. This includes the management of project supplies, filing, development of memos, meeting
minutes and communications covering all operations, including publications. By design, this core will provide
nvestigators with clear lines of scientific and administrative communication to promote collaboration among
.earn members, aid in the prioritization of resources as they relate to the integration and progression of the
program and project specific aims, and facilitate resolution of any problems that affect team members. 2)
rovide statistical analyses for all projects: A) To collaborate with project investigators on a biweekly basis
n the formulation of hypotheses and study design; B) To conduct and direct the statistical analysis of data
ncluding both descriptive summary statistics and sophisticated inferential procedures, including array
analyses; C) Biostatistics efforts shall include timely review, quality assurance, dissemination of the results
gleaned from investigations in all projects; D) Provide specialized microarray data analyses and credentialed
support for this targeted program effort. Under the reorganization of this Core the Biostatistics personnel will
set up and manage a new web based data clearing house for data sharing and data integration for real time
discussions of results between the projects and cores. 3) Organize monthly meetings of the Program
Steering Committee. This Steering committee shall consist of the Project and Core Pis. 4) Organize
Program Project meetings for all members of the project and their laboratory members. 5) Organize Internal
Review Committee meeting where a panel of experts shall assess the Program effectiveness and
experimental progress, research directions, technical approaches, statistical evaluation, and administrative
effectiveness. 6) Organize an annual External Review Committee meeting. The members of External
Review Committee shall review all experimental findings and outcomes, help prioritize investigations, review
the coordination of collaborations, and evaluate concepts that emerge from the studies. 7) Provide
publication services to the investigators for project-related communications where this includes the
preparation of manuscripts, abstracts and other publications. 8} Provide overall fiscal review, accounting
and real time budgets analyses. This includes reports, verbal communications, reviews and forward-looking
projections on expenditures.
行政和生物统计核心将提供关键的中央赠款管理、数据和信息。
新的微阵列数据分析,以及项目的所有统计支持。该核心还将
有助于将研究人员、他们的实验结果和他们的想法、研究的评价
坚定地、批判性地指导总结工作,以保持高度综合的项目成果。的
行政和生物统计核心的具体目标是:(1)为
调查员这包括项目供应的管理,归档,备忘录的开发,会议
包括出版物在内的所有业务的会议记录和通信。根据设计,该核心将提供
研究人员有明确的科学和行政沟通路线,以促进合作,
.赚取成员,在资源的优先次序,因为它们涉及到的整合和发展的援助,
计划和项目的具体目标,并促进解决任何影响团队成员的问题。(二)
为所有项目提供统计分析:A)每两周与项目调查员合作
假设和研究设计的制定; B)进行和指导数据的统计分析
包括描述性汇总统计和复杂的推理程序,包括数组
C)生物统计工作应包括及时审查、质量保证、结果的传播
从所有项目的调查中收集; D)提供专业的微阵列数据分析和认证
支持这项有针对性的计划。根据本核心的重组,生物统计人员将
建立和管理一个新的基于网络的数据交换所,用于真实的实时数据共享和数据集成
项目和核心之间的结果讨论。3)组织方案的月度会议
指导委员会。该指导委员会应由项目和核心PI组成。4)组织
为项目的所有成员及其实验室成员安排项目会议。5)组织内部
审查委员会会议,专家小组应评估计划的有效性,
实验进展、研究方向、技术方法、统计评价和管理
有效性6)组织召开年度外部审查委员会会议。外部成员
审查委员会应审查所有实验发现和结果,帮助确定调查的优先顺序,审查
协调合作,并评估研究中出现的概念。7)提供
向调查人员提供与项目有关的通信出版服务,其中包括
编写手稿、摘要和其他出版物。8}提供全面的财务审查,会计
和真实的时间预算分析。这包括报告、口头沟通、审查和前瞻性
支出预测。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CARLO M CROCE其他文献
CARLO M CROCE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CARLO M CROCE', 18)}}的其他基金
Cancer Gene Discovery to Identify Targetable Targets
癌症基因发现以确定可靶向的靶点
- 批准号:
10250318 - 财政年份:2015
- 资助金额:
$ 9.02万 - 项目类别:
Cancer Gene Discovery to Identify Targetable Targets
癌症基因发现以确定可靶向的靶点
- 批准号:
9321279 - 财政年份:2015
- 资助金额:
$ 9.02万 - 项目类别:
Cancer Gene Discovery to Identify Targetable Targets
癌症基因发现以确定可靶向的靶点
- 批准号:
9763332 - 财政年份:2015
- 资助金额:
$ 9.02万 - 项目类别:
Cancer Gene Discovery to Identify Targetable Targets
癌症基因发现以确定可靶向的靶点
- 批准号:
9143733 - 财政年份:2015
- 资助金额:
$ 9.02万 - 项目类别:
Biologic and Therapeutic Significance of miR-155 in AML
miR-155 在 AML 中的生物学和治疗意义
- 批准号:
9010329 - 财政年份:2015
- 资助金额:
$ 9.02万 - 项目类别:
Identifying non-coding RNAs for early detection and prevention of lung cancer
鉴定非编码 RNA 以早期检测和预防肺癌
- 批准号:
8504396 - 财政年份:2013
- 资助金额:
$ 9.02万 - 项目类别:
Identifying non-coding RNAs for early detection and prevention of lung cancer
鉴定非编码 RNA 以早期检测和预防肺癌
- 批准号:
9302689 - 财政年份:2013
- 资助金额:
$ 9.02万 - 项目类别:
Identifying non-coding RNAs for early detection and prevention of lung cancer
鉴定非编码 RNA 以早期检测和预防肺癌
- 批准号:
8877455 - 财政年份:2013
- 资助金额:
$ 9.02万 - 项目类别:
Identifying non-coding RNAs for early detection and prevention of lung cancer
鉴定非编码 RNA 以早期检测和预防肺癌
- 批准号:
8693965 - 财政年份:2013
- 资助金额:
$ 9.02万 - 项目类别:
相似海外基金
Targeting Menin in Acute Leukemia with Upregulated HOX Genes
通过上调 HOX 基因靶向急性白血病中的 Menin
- 批准号:
10655162 - 财政年份:2023
- 资助金额:
$ 9.02万 - 项目类别:
Rapid Acute Leukemia Genomic Profiling with CRISPR enrichment and Real-time long-read sequencing
利用 CRISPR 富集和实时长读长测序进行快速急性白血病基因组分析
- 批准号:
10839678 - 财政年份:2023
- 资助金额:
$ 9.02万 - 项目类别:
Rapid Acute Leukemia Genomic Profiling with CRISPR enrichment and Real-time long-read sequencing
利用 CRISPR 富集和实时长读长测序进行快速急性白血病基因组分析
- 批准号:
10651543 - 财政年份:2023
- 资助金额:
$ 9.02万 - 项目类别:
Experimental and preclinical modeling of NUP98-rearranged acute leukemia
NUP98重排急性白血病的实验和临床前模型
- 批准号:
10829603 - 财政年份:2023
- 资助金额:
$ 9.02万 - 项目类别:
A Systems Epidemiology Approach for Predicting Methotrexate Neurotoxicity in Pediatric Acute Leukemia
预测儿童急性白血病甲氨蝶呤神经毒性的系统流行病学方法
- 批准号:
10655716 - 财政年份:2023
- 资助金额:
$ 9.02万 - 项目类别:
Anti-CD25 Radioimmunotherapy and Total Marrow Irradiation for Treatment of Relapsed and Refractory Acute Leukemia
抗CD25放射免疫治疗和全骨髓照射治疗复发难治性急性白血病
- 批准号:
10435886 - 财政年份:2022
- 资助金额:
$ 9.02万 - 项目类别:
mRNA stability and its impact on hematopoiesis and acute leukemia
mRNA稳定性及其对造血和急性白血病的影响
- 批准号:
10339742 - 财政年份:2022
- 资助金额:
$ 9.02万 - 项目类别:
Diversifying Acute Leukemia Clinical Trial Enrollment Through Multilevel Intervention
通过多层次干预使急性白血病临床试验招募多样化
- 批准号:
10505579 - 财政年份:2022
- 资助金额:
$ 9.02万 - 项目类别:
Clonal dynamics and chemoresistance mechanisms of minimal residual disease in acute leukemia
急性白血病微小残留病的克隆动力学和化疗耐药机制
- 批准号:
10351765 - 财政年份:2022
- 资助金额:
$ 9.02万 - 项目类别:
Anti-CD25 Radioimmunotherapy and Total Marrow Irradiation for Treatment of Relapsed and Refractory Acute Leukemia
抗CD25放射免疫治疗和全骨髓照射治疗复发难治性急性白血病
- 批准号:
10576955 - 财政年份:2022
- 资助金额:
$ 9.02万 - 项目类别: